UY39856A - Inhibidores peptídicos del receptor de interleucina-23 - Google Patents
Inhibidores peptídicos del receptor de interleucina-23Info
- Publication number
- UY39856A UY39856A UY0001039856A UY39856A UY39856A UY 39856 A UY39856 A UY 39856A UY 0001039856 A UY0001039856 A UY 0001039856A UY 39856 A UY39856 A UY 39856A UY 39856 A UY39856 A UY 39856A
- Authority
- UY
- Uruguay
- Prior art keywords
- interleukin
- receptor
- peptide inhibitors
- disorders
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221806P | 2021-07-14 | 2021-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY39856A true UY39856A (es) | 2023-02-28 |
Family
ID=84920532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001039856A UY39856A (es) | 2021-07-14 | 2022-07-14 | Inhibidores peptídicos del receptor de interleucina-23 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240409598A1 (https=) |
| EP (1) | EP4370531A4 (https=) |
| JP (1) | JP2024525780A (https=) |
| KR (1) | KR20240034222A (https=) |
| CN (1) | CN117999274A (https=) |
| AU (1) | AU2022310354A1 (https=) |
| CA (1) | CA3226539A1 (https=) |
| MX (1) | MX2024000762A (https=) |
| TW (1) | TW202332683A (https=) |
| UY (1) | UY39856A (https=) |
| WO (1) | WO2023288028A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| EP4652180A2 (en) * | 2023-01-16 | 2025-11-26 | Janssen Pharmaceutica NV | Peptide inhibitors of interleukin-23 receptor |
| US20240279281A1 (en) * | 2023-01-16 | 2024-08-22 | Janssen Pharmaceutica Nv | Peptide Inhibitors of Interleukin-23 Receptor |
| WO2024155553A1 (en) * | 2023-01-16 | 2024-07-25 | Janssen Pharmaceutica Nv | Lipidated peptide inhibitors of interleukin-23 receptor |
| IL322423A (en) * | 2023-01-31 | 2025-09-01 | Janssen Pharmaceutica Nv | Methods for preparing crystalline peptide inhibitors of the interleukin-23 receptor |
| CN120826233A (zh) * | 2023-03-03 | 2025-10-21 | 詹森药业有限公司 | 用于治疗银屑病的白介素-23受体拮抗剂肽 |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121909205A (zh) | 2023-09-08 | 2026-04-21 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| CN121794283A (zh) | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026026816A1 (zh) * | 2024-07-30 | 2026-02-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂及其用途 |
| WO2026041110A1 (zh) * | 2024-08-22 | 2026-02-26 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
| WO2026046292A1 (zh) * | 2024-08-28 | 2026-03-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂的药物组合物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| CN107206254B (zh) * | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US10787490B2 (en) * | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| MX384213B (es) * | 2015-07-15 | 2025-03-14 | Protagonist Therapeutics Inc | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. |
| WO2018136646A1 (en) * | 2017-01-18 | 2018-07-26 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2020014646A1 (en) * | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7534382B2 (ja) * | 2019-07-10 | 2024-08-14 | プロタゴニスト セラピューティクス， インコーポレイテッド | インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 |
| WO2021007433A1 (en) * | 2019-07-10 | 2021-01-14 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) * | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
-
2022
- 2022-07-14 TW TW111126555A patent/TW202332683A/zh unknown
- 2022-07-14 UY UY0001039856A patent/UY39856A/es unknown
- 2022-07-14 JP JP2024501976A patent/JP2024525780A/ja active Pending
- 2022-07-14 WO PCT/US2022/037221 patent/WO2023288028A2/en not_active Ceased
- 2022-07-14 CA CA3226539A patent/CA3226539A1/en active Pending
- 2022-07-14 US US18/579,062 patent/US20240409598A1/en active Pending
- 2022-07-14 AU AU2022310354A patent/AU2022310354A1/en active Pending
- 2022-07-14 MX MX2024000762A patent/MX2024000762A/es unknown
- 2022-07-14 CN CN202280061973.9A patent/CN117999274A/zh active Pending
- 2022-07-14 KR KR1020247004772A patent/KR20240034222A/ko active Pending
- 2022-07-14 EP EP22842905.6A patent/EP4370531A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022310354A1 (en) | 2024-02-29 |
| EP4370531A2 (en) | 2024-05-22 |
| KR20240034222A (ko) | 2024-03-13 |
| JP2024525780A (ja) | 2024-07-12 |
| EP4370531A4 (en) | 2025-09-03 |
| WO2023288028A2 (en) | 2023-01-19 |
| TW202332683A (zh) | 2023-08-16 |
| CN117999274A (zh) | 2024-05-07 |
| MX2024000762A (es) | 2024-04-18 |
| US20240409598A1 (en) | 2024-12-12 |
| CA3226539A1 (en) | 2023-01-19 |
| WO2023288028A3 (en) | 2023-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY39856A (es) | Inhibidores peptídicos del receptor de interleucina-23 | |
| UY39858A (es) | Inhibidores peptídicos bicíclicos del receptor de interleucina-23 | |
| CO2023007172A2 (es) | Composiciones de inhibidores peptídicos del receptor de interleucina-23 | |
| UY39857A (es) | Inhibidores peptídicos lipidados del receptor de interleucina-23 | |
| ECSP22063238A (es) | Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias | |
| MX2022008740A (es) | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. | |
| AR119389A1 (es) | Inhibidores de péptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias | |
| CO2024005925A2 (es) | Moléculas pequeñas para el tratamiento del cáncer | |
| BR112022000328A2 (pt) | Inibidores peptídicos do receptor de interleucina-23 e seu uso para tratar doenças inflamatórias | |
| CY1125488T1 (el) | Παραγωγα πυριδινης και θεραπευτικες χρησεις αυτων ως αναστολεις trpc6 | |
| MX2024009477A (es) | Inhibidores peptídicos del receptor de interleucina-23 y composiciones farmacéuticas de estos | |
| TR201816176T4 (tr) | Histon deasetilaz 6 inhibitörleri olarak yeni bileşikler ve bunu içeren farmasötik bileşimler. | |
| AR101871A1 (es) | Composiciones de glicoconjugado inmunogénico / terapéutico y sus usos | |
| CR20230177A (es) | Compuestos y composiciones como moduladores de señalización tlr | |
| JOP20230089A1 (ar) | مثبطات إنترليوكين-17 | |
| MX2025008274A (es) | Formulaciones de inhibidores peptidicos lipidados del receptor de interleucina-23 | |
| JOP20230150A1 (ar) | صيغ ببتيد علاجية | |
| WO2024155547A3 (en) | Peptide inhibitors of interleukin-23 receptor | |
| CO2025010249A2 (es) | Inhibidores peptídicos del receptor de interleucina-23 | |
| DOP2025000151A (es) | Inhibidores peptídicos del receptor de interleucina-23 | |
| UY40134A (es) | Motor de presión negativa | |
| MX2021007417A (es) | Formas cristalinas de un inhibidor del receptor 4 activado por proteasa (par4). |